NCT00061945 2022-05-03Alemtuzumab and Combination Chemotherapy in Treating Patients With Untreated Acute Lymphoblastic LeukemiaNational Cancer Institute (NCI)Phase 1/2 Completed302 enrolled 11 charts
NCT00045292 2010-09-21Valacyclovir in Preventing Cytomegalovirus Infection in Patients Who Are Undergoing Donor Stem Cell TransplantationFred Hutchinson Cancer CenterPhase 3 Completed